Kewaunee Scientific (KEQU) Competitors $58.64 +1.04 (+1.81%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock KEQU vs. LAB, AEHR, CTKB, SENS, QSI, QTRX, MASS, FEIM, RPID, and OWLTShould you be buying Kewaunee Scientific stock or one of its competitors? The main competitors of Kewaunee Scientific include Standard BioTools (LAB), Aehr Test Systems (AEHR), Cytek Biosciences (CTKB), Senseonics (SENS), Quantum-Si (QSI), Quanterix (QTRX), 908 Devices (MASS), Frequency Electronics (FEIM), Rapid Micro Biosystems (RPID), and Owlet (OWLT). These companies are all part of the "measuring and control equipment" industry. Kewaunee Scientific vs. Its Competitors Standard BioTools Aehr Test Systems Cytek Biosciences Senseonics Quantum-Si Quanterix 908 Devices Frequency Electronics Rapid Micro Biosystems Owlet Standard BioTools (NASDAQ:LAB) and Kewaunee Scientific (NASDAQ:KEQU) are both small-cap measuring and control equipment companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, media sentiment, analyst recommendations, valuation and risk. Which has better earnings & valuation, LAB or KEQU? Kewaunee Scientific has higher revenue and earnings than Standard BioTools. Standard BioTools is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioStandard BioTools$174.43M3.05-$138.88M-$0.35-4.00Kewaunee Scientific$240.47M0.72$11.40M$3.8315.36 Do insiders and institutionals believe in LAB or KEQU? 53.7% of Standard BioTools shares are held by institutional investors. Comparatively, 32.7% of Kewaunee Scientific shares are held by institutional investors. 23.2% of Standard BioTools shares are held by company insiders. Comparatively, 13.3% of Kewaunee Scientific shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has more volatility and risk, LAB or KEQU? Standard BioTools has a beta of 1.54, indicating that its stock price is 54% more volatile than the S&P 500. Comparatively, Kewaunee Scientific has a beta of 0.7, indicating that its stock price is 30% less volatile than the S&P 500. Is LAB or KEQU more profitable? Kewaunee Scientific has a net margin of 4.74% compared to Standard BioTools' net margin of -78.24%. Kewaunee Scientific's return on equity of 26.02% beat Standard BioTools' return on equity.Company Net Margins Return on Equity Return on Assets Standard BioTools-78.24% -22.44% -16.74% Kewaunee Scientific 4.74%26.02%9.87% Do analysts prefer LAB or KEQU? Standard BioTools presently has a consensus price target of $2.50, indicating a potential upside of 78.57%. Given Standard BioTools' stronger consensus rating and higher possible upside, equities analysts plainly believe Standard BioTools is more favorable than Kewaunee Scientific.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Standard BioTools 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 3.00Kewaunee Scientific 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media refer more to LAB or KEQU? In the previous week, Standard BioTools and Standard BioTools both had 2 articles in the media. Kewaunee Scientific's average media sentiment score of 1.28 beat Standard BioTools' score of 0.97 indicating that Kewaunee Scientific is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Standard BioTools 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Kewaunee Scientific 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryKewaunee Scientific beats Standard BioTools on 8 of the 15 factors compared between the two stocks. Get Kewaunee Scientific News Delivered to You Automatically Sign up to receive the latest news and ratings for KEQU and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding KEQU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KEQU vs. The Competition Export to ExcelMetricKewaunee ScientificINSTRU IndustryComputer SectorNASDAQ ExchangeMarket Cap$169.72M$1.07B$29.03B$9.51BDividend YieldN/A0.49%3.02%4.01%P/E Ratio15.3632.0134.2120.05Price / Sales0.721.461,733.0599.42Price / Cash7.8432.2638.3858.56Price / Book2.543.517.795.87Net Income$11.40M$17.67M$782.91M$258.55M7 Day Performance5.73%4.67%0.96%2.23%1 Month Performance45.36%8.83%7.50%12.76%1 Year Performance8.82%-26.19%53,041.27%19.36% Kewaunee Scientific Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KEQUKewaunee Scientific1.0366 of 5 stars$58.84+2.2%N/A+7.2%$169.72M$240.47M15.361,239Positive NewsLABStandard BioTools3.502 of 5 stars$1.26+2.4%$2.50+98.4%-34.7%$467.18M$174.43M-3.60620News CoverageUpcoming EarningsAEHRAehr Test Systems1.8784 of 5 stars$16.45+9.2%N/A+25.1%$448.65M$58.97M-126.5390Insider TradeCTKBCytek Biosciences3.2212 of 5 stars$3.10-1.0%$5.60+80.6%-47.0%$396.44M$200.45M-34.44500News CoveragePositive NewsGap UpSENSSenseonics2.0909 of 5 stars$0.58-0.4%$1.55+168.3%+24.8%$378.01M$23.68M-4.4490Positive NewsQSIQuantum-Si2.255 of 5 stars$1.72-2.3%$3.48+102.0%+90.4%$322.96M$3.06M-2.53150Positive NewsQTRXQuanterix2.6298 of 5 stars$5.18-3.5%$13.50+160.6%-64.1%$268.25M$133.92M-3.98460Positive NewsMASS908 Devices1.3093 of 5 stars$6.96+3.9%$5.33-23.4%+37.2%$240.27M$59.63M-12.8960News CoveragePositive NewsFEIMFrequency Electronics1.5661 of 5 stars$23.22+8.2%N/A+92.8%$207.76M$69.81M9.40200High Trading VolumeRPIDRapid Micro Biosystems2.1578 of 5 stars$3.40-0.3%$8.00+135.3%+552.5%$149.47M$28.05M-3.30200Upcoming EarningsOWLTOwlet1.4381 of 5 stars$7.74-3.5%$10.25+32.4%+103.6%$132.53M$78.10M-5.41106News Coverage Related Companies and Tools Related Companies LAB Alternatives AEHR Alternatives CTKB Alternatives SENS Alternatives QSI Alternatives QTRX Alternatives MASS Alternatives FEIM Alternatives RPID Alternatives OWLT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KEQU) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kewaunee Scientific Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Kewaunee Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
